書誌事項
- タイトル別名
-
- Production of an active form of vitamin D_3 by a recombinant actinomycete expressing genetically engineered CYP105A1
- CYP105A1ニジュウ ヘンイタイ オ ハツゲン スル ホウセンキン オ モチイタ カッセイガタ ビタミン D3 ノ セイサン
この論文をさがす
抄録
Our previous studies revealed that the double mutant of CYP105A1 from Streptomyces griseolus, R73V/R84A, has a high ability to convert vitamin D_3(VD_3) to its biologically active form, 1α,25-dihydroxyvitamin D_3(1α,25(OH)_2D_3), suggesting the possibility of practical application of R73V/R84A to produce 1α,25(OH)_2D_3. Thus, we examined the expression of R73V/R84A in Streptomyces lividans TK23. As expected, the metabolites 25(OH)D_3 and 1α,25(OH)_2D_3 were detected in the recombinant S. lividans cell culture. In addition, novel polar metabolites 1α,25(R),26(OH)_3D_3 and 1α,25(S),26(OH)_3D_3, both of which were known to have a high antiproliferative activity and a low calcemic activity, were observed at a ratio of 5:1. The crystal structure of the double mutant with 1α,25(OH)_2D_3 and a conformational search of 1α,25(OH)_2D_3 in its active site strongly suggest that a novel hydrogen-bond network including 1α-hydroxyl group and several water molecules plays an important role in the substrate-binding for 26-hydroxylation. In conclusion, we demonstrated that R73V/R84A can catalyze hydroxylations at C25-, C1- and C26 (27) positions of VD_3 to produce biologically useful compounds.
収録刊行物
-
- ビタミン
-
ビタミン 85 (3), 109-114, 2011
公益社団法人 日本ビタミン学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001205701396736
-
- NII論文ID
- 110008607853
-
- NII書誌ID
- AN00207833
-
- ISSN
- 2424080X
- 0006386X
-
- NDL書誌ID
- 11053502
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可